Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-01

Clinical Trial Update: A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating human TH-SC01 cell injections for perianal fistulas in Crohn's disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human TH-SC01 Cell Injection

Snippet

Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd. | Conditions: Perianal Fistula, Crohn's Disease | Phase 1, Phase 2 | Status: COMPLETED